Clinical Trials Browser

Phase 2/3 × Suspended × Carcinoma, Hepatocellular × Clear all

NCT05033522 2025-10-23

ALIVE

Phase 2/3 Suspended

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT04268888 2025-02-26

TACE-3

Phase 2/3 Suspended

Gastrointestinal

Carcinoma, Hepatocellular